ETFs Bayer AG

BAYN

DE000BAY0017

Name	Weight	AuM	1st Jan change
LYXOR DIVDAX (DR) UCITS ETF - EUR	9.77%	0 M€	-.--%	-
LYXOR CORE DAX (DR) UCITS ETF - EUR	4.28%	962 M€	-.--%	-
LEVERAGE SHARES -3X SHORT GERMANY 40 ETP SECURITIES - EUR	4.1%	1 M€	0.00%	-
LEVERAGE SHARES 3X LONG GERMANY 40 ETP SECURITIES - EUR	4.1%	0 M€	+66.38%	-
LYXOR F.A.Z. 100 INDEX (DR) UCITS ETF - EUR	3.03%	0 M€	-.--%	-
BBVA ACCION DJ EUROSTOXX 50 ETF - EUR	1.91%	137 M€	+12.78%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	1.52%	21 M€	+4.65%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	0.53%	0 M€	-.--%	-
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.42%	1,022 M€	+19.81%	-
DEMOCRACY INTERNATIONAL FUND ETF - USD	0.31%	9 M€	+14.63%	-
VANECK INFLATION ALLOCATION ETF - USD	0.28%	101 M€	+13.05%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0.26%	33,076 M€	+10.40%	-
GOOSE HOLLOW TACTICAL ALLOCATION ETF - USD	0.21%	38 M€	+8.11%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.18%	32 M€	+14.14%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.13%	331 M€	+1.80%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.09%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.09%	0 M€	-.--%	-
LEVERAGE SHARES PLC - 3X LONG TOTAL WORLD ETP	0.09%	1 M€	-.--%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.07%	619 M€	-0.89%	-

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

90,885

Sector

Pharmaceuticals

Calendar

Aug. 06 - Q2 2025 Earnings Release

More about the company